Abstract
Hypersalivation is a common and frequently disabling side effect of atypical neuroleptics such as clozapine. Current treatment options of this adverse advent are limited by lack of efficacy or additional side effects. Botulinum toxin (BTX) injections into the parotid glands have been shown to be very effective in treating sialorrhea in the context of various neurological disorders, such as Parkinson’s and motor neuron disease. Surprisingly, BTX treatment of drug-induced sialorrhea has not yet been described. We here report a patient with clozapine-induced hypersalivation and a good response to BTX injections lasting for more than 12 weeks, resulting in a marked reduction of the hypersalivation and consequently of his social withdrawal. Our patient serves to alert clinicians to the frequent problem of drug-induced sialorrhea and suggests that BTX injections should be considered as an effective and safe treatment for hypersalivation in psychiatric patients treated with clozapine.
Similar content being viewed by others
References
Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C (2003) Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg 61:454–457
Kerner J (1817) Vergiftung durch verdorbene Würste. Tübinger Blätt Neurowissenschaften Arzneykunde 3:1–25
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82–91
Miller DD (2000) Review and management of clozapine side effects. J Clin Psychiatry 61:14–19
Rogers DP, Pharm D, Shramko JK (2000) Therapeutic options in the treatment of clozapine-induced sialorrhea. Pharmacotherapy 20:1092–1095
Author information
Authors and Affiliations
Corresponding author
Additional information
The first two authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kahl, K.G., Hagenah, J., Zapf, S. et al. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology 173, 229–230 (2004). https://doi.org/10.1007/s00213-004-1803-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-1803-0